Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and January 2019

Showing 1 to 10 of 410
Title Reference number Published Last updated
Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer Reference number:TA557 TA00557 Published:January 2019 20190101 Last updated:January 2019 20190110
Regorafenib for previously treated advanced hepatocellular carcinoma Reference number:TA555 TA00555 Published:January 2019 20190101 Last updated:January 2019 20190109
Darvadstrocel for treating complex perianal fistulas in Crohn’s disease Reference number:TA556 TA00556 Published:January 2019 20190101 Last updated:January 2019 20190109
Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years Reference number:TA554 TA00554 Published:December 2018 20181201 Last updated:December 2018 20181221
Lenvatinib for untreated advanced hepatocellular carcinoma Reference number:TA551 TA00551 Published:December 2018 20181201 Last updated:December 2018 20181219
Liposomal cytarabine–daunorubicin for untreated acute myeloid leukaemia Reference number:TA552 TA00552 Published:December 2018 20181201 Last updated:December 2018 20181219
Pembrolizumab for adjuvant treatment of resected melanoma with high risk of recurrence Reference number:TA553 TA00553 Published:December 2018 20181201 Last updated:December 2018 20181219
Vandetanib for treating medullary thyroid cancer Reference number:TA550 TA00550 Published:December 2018 20181201 Last updated:December 2018 20181212
Decitabine for untreated acute myeloid leukaemia (terminated appraisal) Reference number:TA548 TA00548 Published:December 2018 20181201 Last updated:December 2018 20181205
Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal) Reference number:TA549 TA00549 Published:December 2018 20181201 Last updated:December 2018 20181205